Amgen (AMGN): FY25 Q2 earnings call, Aug 5, 2025

Tue, Aug 5Earnings callSpeaker-labelled transcriptAmgen

No Kalshi or Polymarket word markets were listed for Amgen’s Aug 5, 2025 earnings call (FY25 Q2). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

1 match for “Eosinophilic”; 1 quoted, at least 25 words apart.

James E. Bradnercompanyprepared

…per microliter. Beyond COPD, enrollment was recently completed in our Phase III eosinophilic esophagitis study, and we look forward to the October 19 PDUFA date…

Agents: this page as TSV at /api/v1/appearances/amgen:2025-08-05:earnings_call · words: /api/v1/brief?appearance=amgen:2025-08-05:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP